IRF4 deficiency vulnerates B-cell progeny for leukemogenesis via somatically acquired Jak3 mutations conferring IL-7 hypersensitivity

IRF4 缺陷通过体细胞获得的 Jak3 突变赋予 IL-7 超敏反应,使 B 细胞后代易患白血病。

阅读:3
作者:Dennis Das Gupta,Christoph Paul,Nadine Samel,Maria Bieringer,Daniel Staudenraus,Federico Marini,Hartmann Raifer,Lisa Menke,Lea Hansal,Bärbel Camara,Edith Roth,Patrick Daum,Michael Wanzel,Marco Mernberger,Andrea Nist,Uta-Maria Bauer,Frederik Helmprobst,Malte Buchholz,Katrin Roth,Lorenz Bastian,Alina M Hartmann,Claudia Baldus,Koichi Ikuta,Andreas Neubauer,Andreas Burchert,Hans-Martin Jäck,Matthias Klein,Tobias Bopp,Thorsten Stiewe,Axel Pagenstecher,Michael Lohoff

Abstract

The processes leading from disturbed B-cell development to adult B-cell progenitor acute lymphoblastic leukemia (BCP-ALL) remain poorly understood. Here, we describe Irf4-/- mice as prone to developing BCP-ALL with age. Irf4-/- preB-I cells exhibited impaired differentiation but enhanced proliferation in response to IL-7, along with reduced retention in the IL-7 providing bone marrow niche due to decreased CXCL12 responsiveness. Thus selected, preB-I cells acquired Jak3 mutations, probably following irregular AID activity, resulting in malignant transformation. We demonstrate heightened IL-7 sensitivity due to Jak3 mutants, devise a model to explain it, and describe structural and functional similarities to Jak2 mutations often occurring in human Ph-like ALL. Finally, targeting JAK signaling with Ruxolitinib in vivo prolonged survival of mice bearing established Irf4-/- leukemia. Intriguingly, organ infiltration including leukemic meningeosis was selectively reduced without affecting blood blast counts. In this work, we present spontaneous leukemogenesis following IRF4 deficiency with potential implications for high-risk BCP-ALL in adult humans.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。